{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T13:27:32Z","timestamp":1792848452114,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Safe and effective vaccines against co-circulating mosquito-borne orthoflaviviruses such as Zika virus (ZikV) and the four serotypes of Dengue virus (DenV1-4) must elicit broadly neutralizing antibodies (bnAbs) to prevent the risk of enhancement of infection by non-neutralizing antibodies. We recently discovered new orthoflavivirus-directed bnAbs, including F25.S02, which neutralizes DenV1-4 and ZikV with comparable or superior potency to the previously characterized E dimer epitope (EDE) bnAbs. Here, we used cryoEM and X-ray crystallography to understand the basis of cross-neutralization of F25.S02 at the molecular level. We obtained a\u2009~\u20094.2\u2009\u00c5 cryoEM structure of F25.S02 Fab bound to a stabilized DenV3 soluble E protein dimer and a 2.3\u2009\u00c5 crystal structure of F25.S02 Fab bound to ZikV soluble E protein dimer. Like previously described EDE1 bnAbs, the structural epitope of F25.S02 is at the E dimer interface, encompassing predominantly conserved regions in domain II, including the fusion loop. However, unlike EDE1 bnAbs, F25.S02 binding is almost entirely dependent on the heavy chain and is shifted slightly away from the dimer symmetry axis. Our findings emphasize the importance of this cross-neutralizing site of vulnerability for DenV and ZikV that can facilitate rational design of vaccines and therapeutics.<\/jats:p>","DOI":"10.1038\/s42003-026-09805-6","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T17:34:41Z","timestamp":1773164081000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Structural basis for antibody cross-neutralization of Dengue and Zika viruses"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9891-916X","authenticated-orcid":false,"given":"Nicholas K.","family":"Hurlburt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7125-453X","authenticated-orcid":false,"given":"Jay","family":"Lubow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Goo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9217-6270","authenticated-orcid":false,"given":"Marie","family":"Pancera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"9805_CR1","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504\u2013507 (2013).","journal-title":"Nature"},{"key":"9805_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.antiviral.2016.03.010","volume":"130","author":"SC Weaver","year":"2016","unstructured":"Weaver, S. C. et al. Zika virus: history, emergence, biology, and prospects for control. Antivir. Res. 130, 69\u201380 (2016).","journal-title":"Antivir. Res."},{"key":"9805_CR3","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41564-019-0376-y","volume":"4","author":"MUG Kraemer","year":"2019","unstructured":"Kraemer, M. U. G. et al. Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus. Nat. Microbiol. 4, 854\u2013863 (2019).","journal-title":"Nat. Microbiol."},{"key":"9805_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16010-4","volume":"11","author":"T Iwamura","year":"2020","unstructured":"Iwamura, T., Guzman-Holst, A. & Murray, K. A. Accelerating invasion potential of disease vector Aedes aegypti under climate change. Nat. Commun. 11, 2130 (2020).","journal-title":"Nat. Commun."},{"key":"9805_CR5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","volume":"108","author":"RJ Kuhn","year":"2002","unstructured":"Kuhn, R. J. et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108, 717\u2013725 (2002).","journal-title":"Cell"},{"key":"9805_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/375291a0","volume":"375","author":"FA Rey","year":"1995","unstructured":"Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C. & Harrison, S. C. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 375, 291\u2013298 (1995).","journal-title":"Nature"},{"key":"9805_CR7","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.aaf8505","volume":"353","author":"K Stettler","year":"2016","unstructured":"Stettler, K. et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353, 823\u2013826 (2016).","journal-title":"Science"},{"key":"9805_CR8","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aan6836","volume":"358","author":"LC Katzelnick","year":"2017","unstructured":"Katzelnick, L. C. et al. Antibody-dependent enhancement of severe dengue disease in humans. Science 358, 929\u2013932 (2017).","journal-title":"Science"},{"key":"9805_CR9","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1126\/science.abb6143","volume":"369","author":"LC Katzelnick","year":"2020","unstructured":"Katzelnick, L. C. et al. Zika virus infection enhances future risk of severe dengue disease. Science 369, 1123\u20131128 (2020).","journal-title":"Science"},{"key":"9805_CR10","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1016\/j.vaccine.2018.09.063","volume":"37","author":"Dengue vaccine","year":"2019","unstructured":"Dengue vaccine WHO position paper, September 2018 - Recommendations. Vaccine 37, 4848\u20134849 (2019).","journal-title":"Vaccine"},{"key":"9805_CR11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/21645515.2018.1522468","volume":"15","author":"HJ Larson","year":"2019","unstructured":"Larson, H. J., Hartigan-Go, K. & de Figueiredo, A. Vaccine confidence plummets in the Philippines following dengue vaccine scare: why it matters to pandemic preparedness. Hum. Vaccin Immunother. 15, 625\u2013627 (2019).","journal-title":"Hum. Vaccin Immunother."},{"key":"9805_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ni.3058","volume":"16","author":"W Dejnirattisai","year":"2015","unstructured":"Dejnirattisai, W. et al. A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat. Immunol. 16, 170\u2013177 (2015).","journal-title":"Nat. Immunol."},{"key":"9805_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature14130","volume":"520","author":"A Rouvinski","year":"2015","unstructured":"Rouvinski, A. et al. Recognition determinants of broadly neutralizing human antibodies against dengue viruses. Nature 520, 109\u2013113 (2015).","journal-title":"Nature"},{"key":"9805_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nature18938","volume":"536","author":"G Barba-Spaeth","year":"2016","unstructured":"Barba-Spaeth, G. et al. Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature 536, 48\u201353 (2016).","journal-title":"Nature"},{"key":"9805_CR15","doi-asserted-by":"publisher","unstructured":"Kam, Y.W. et al. Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections. JCI Insight. 2, Epub 20170420. https:\/\/doi.org\/10.1172\/jci.insight.92428. (2017).","DOI":"10.1172\/jci.insight.92428"},{"key":"9805_CR16","doi-asserted-by":"publisher","first-page":"107584","DOI":"10.1016\/j.celrep.2020.107584","volume":"31","author":"S Zhang","year":"2020","unstructured":"Zhang, S. et al. A human antibody neutralizes different flaviviruses by using different mechanisms. Cell Rep. 31, 107584 (2020).","journal-title":"Cell Rep."},{"key":"9805_CR17","doi-asserted-by":"publisher","first-page":"e1011722","DOI":"10.1371\/journal.ppat.1011722","volume":"19","author":"J Lubow","year":"2023","unstructured":"Lubow, J. et al. Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses. PLOS Pathog. 19, e1011722 (2023).","journal-title":"PLOS Pathog."},{"key":"9805_CR18","unstructured":"FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine [Internet]. U.S. Food and Drug Administration; 2023. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine."},{"key":"9805_CR19","doi-asserted-by":"publisher","first-page":"102079","DOI":"10.1016\/j.jbc.2022.102079","volume":"298","author":"TTN Phan","year":"2022","unstructured":"Phan, T. T. N. et al. A conserved set of mutations for stabilizing soluble envelope protein dimers from dengue and Zika viruses to advance the development of subunit vaccines. J. Biol. Chem. 298, 102079 (2022).","journal-title":"J. Biol. Chem."},{"key":"9805_CR20","doi-asserted-by":"publisher","first-page":"6052","DOI":"10.1016\/j.cell.2021.11.010","volume":"184","author":"A Sharma","year":"2021","unstructured":"Sharma, A. et al. The epitope arrangement on flavivirus particles contributes to Mab C10\u2019s extraordinary neutralization breadth across Zika and dengue viruses. Cell 184, 6052\u201366.e18 (2021).","journal-title":"Cell"},{"key":"9805_CR21","doi-asserted-by":"publisher","first-page":"e4582","DOI":"10.1002\/pro.4582","volume":"32","author":"B Yariv","year":"2023","unstructured":"Yariv, B. et al. Using evolutionary data to make sense of macromolecules with a \u201cface-lifted\u201d ConSurf. Protein Sci. 32, e4582 (2023).","journal-title":"Protein Sci."},{"key":"9805_CR22","doi-asserted-by":"publisher","first-page":"e0304823","DOI":"10.1128\/mbio.03048-23","volume":"15","author":"M Contreras","year":"2024","unstructured":"Contreras, M., Stuart, J. B., Levoir, L. M., Belmont, L. & Goo, L. Defining the impact of flavivirus envelope protein glycosylation site mutations on sensitivity to broadly neutralizing antibodies. mBio 15, e0304823 (2024).","journal-title":"mBio"},{"key":"9805_CR23","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1126\/science.1192819","volume":"329","author":"T Zhou","year":"2010","unstructured":"Zhou, T. et al. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 329, 811\u2013817 (2010).","journal-title":"Science"},{"key":"9805_CR24","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1016\/j.celrep.2019.10.071","volume":"29","author":"KR Parks","year":"2019","unstructured":"Parks, K. R. et al. Overcoming steric restrictions of VRC01 HIV-1 neutralizing antibodies through immunization. Cell Rep. 29, 3060\u201372 e7 (2019).","journal-title":"Cell Rep."},{"key":"9805_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.immuni.2019.06.004","volume":"51","author":"J Umotoy","year":"2019","unstructured":"Umotoy, J. et al. Rapid and focused maturation of a VRC01-Class HIV broadly neutralizing antibody lineage involves both binding and accommodation of the N276-Glycan. Immunity 51, 141\u201354.e6 (2019).","journal-title":"Immunity"},{"key":"9805_CR26","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.str.2018.05.006","volume":"26","author":"M Sevvana","year":"2018","unstructured":"Sevvana, M. et al. Refinement and analysis of the mature Zika virus Cryo-EM structure at 3.1 a resolution. Structure 26, 1169\u201377.e3 (2018).","journal-title":"Structure"},{"key":"9805_CR27","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.chom.2019.10.005","volume":"26","author":"KH Ng","year":"2019","unstructured":"Ng, K. H. et al. Persistent dengue infection in an immunosuppressed patient reveals the roles of humoral and cellular immune responses in virus clearance. Cell Host Microbe 26, 601\u20135 e3 (2019).","journal-title":"Cell Host Microbe"},{"key":"9805_CR28","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/infdis\/jiz081","volume":"221","author":"M Sharma","year":"2020","unstructured":"Sharma, M. et al. Magnitude and functionality of the NS1-specific antibody response elicited by a live-attenuated tetravalent dengue vaccine candidate. J. Infect. Dis. 221, 867\u2013877 (2020).","journal-title":"J. Infect. Dis."},{"key":"9805_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 (2005).","journal-title":"J. Struct. Biol."},{"key":"9805_CR30","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/s41592-019-0580-y","volume":"16","author":"D Tegunov","year":"2019","unstructured":"Tegunov, D. & Cramer, P. Real-time cryo-electron microscopy data preprocessing with Warp. Nat. Methods 16, 1146\u20131152 (2019).","journal-title":"Nat. Methods"},{"key":"9805_CR31","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"9805_CR32","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41592-020-00990-8","volume":"17","author":"A Punjani","year":"2020","unstructured":"Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214\u20131221 (2020).","journal-title":"Nat. Methods"},{"key":"9805_CR33","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"9805_CR34","doi-asserted-by":"publisher","first-page":"e4792","DOI":"10.1002\/pro.4792","volume":"32","author":"EC Meng","year":"2023","unstructured":"Meng, E. C. et al. UCSF ChimeraX: tools for structure building and analysis. Protein Sci. 32, e4792 (2023).","journal-title":"Protein Sci."},{"key":"9805_CR35","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"9805_CR36","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D. Struct. Biol. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. D. Struct. Biol."},{"key":"9805_CR37","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1107\/S2059798318002425","volume":"74","author":"TI Croll","year":"2018","unstructured":"Croll, T. I. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. D. Struct. Biol. 74, 519\u2013530 (2018).","journal-title":"Acta Crystallogr. D. Struct. Biol."},{"key":"9805_CR38","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","volume":"372","author":"E Krissinel","year":"2007","unstructured":"Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774\u2013797 (2007).","journal-title":"J. Mol. Biol."},{"key":"9805_CR39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. Xds. Acta Crystallogr. D. Biol. Crystallogr. 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"9805_CR40","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1107\/S2059798323003595","volume":"79","author":"J Agirre","year":"2023","unstructured":"Agirre, J. et al. The CCP4 suite: integrative software for macromolecular crystallography. Acta Crystallogr. D. Struct. Biol. 79, 449\u2013461 (2023).","journal-title":"Acta Crystallogr. D. Struct. Biol."},{"key":"9805_CR41","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","volume":"19","author":"L Dai","year":"2016","unstructured":"Dai, L. et al. Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody. Cell Host Microbe 19, 696\u2013704 (2016).","journal-title":"Cell Host Microbe"},{"key":"9805_CR42","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pro.3330","volume":"27","author":"CJ Williams","year":"2018","unstructured":"Williams, C. J. et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci. 27, 293\u2013315 (2018).","journal-title":"Protein Sci."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09805-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09805-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09805-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T11:03:06Z","timestamp":1777028586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09805-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9805"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-09805-6","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.L. and L.G. are inventors on a patent application filed by Fred Hutchinson Cancer Center relating to F25.S02. L.G is an employee and a possible shareholder of Vaccine Company, Inc. The other authors have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"568"}}